Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS · Delayed Price · Currency is USD
9.20
-0.05 (-0.54%)
Sep 3, 2025, 3:47 PM EDT
Telix Pharmaceuticals Revenue
Telix Pharmaceuticals had revenue of $390.36M in the half year ending June 30, 2025, with 165.59% growth. This brings the company's revenue in the last twelve months to $664.23M, up 55.35% year-over-year. In the year 2024, Telix Pharmaceuticals had annual revenue of $484.69M with 41.49% growth.
Revenue (ttm)
664.23M
Revenue Growth
+55.35%
P/S Ratio
4.72
Revenue / Employee
1.57M
Employees
234
Market Cap
3.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 484.69M | 142.12M | 41.49% |
Dec 31, 2023 | 342.57M | 233.76M | 214.82% |
Dec 31, 2022 | 108.81M | 103.29M | 1,870.12% |
Dec 31, 2021 | 5.52M | 1.50M | 37.33% |
Dec 31, 2020 | 4.02M | 1.57M | 64.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Longduoduo Company | 4.99M |
Telix Pharmaceuticals News
- 16 hours ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX - PRNewsWire
- 5 days ago - Telix Pharmaceuticals Limited (TLX) Hits Another Roadblock After SEC Subpoena, Shares Fall Again -- Hagens Berman - GlobeNewsWire
- 5 days ago - Telix Pharmaceuticals: Roadblocks Piling Up, But They're Not Insurmountable - Seeking Alpha
- 5 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX - GlobeNewsWire
- 6 days ago - Telix Gets Second FDA Rejection For Kidney Cancer Drug - Benzinga
- 6 days ago - Telix Gets Second FDA Rejection For Kidney Cancer Drug - Benzinga
- 7 days ago - US FDA seeks more information on Telix Pharma's diagnostic drug for kidney cancer - Reuters
- 7 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX - PRNewsWire